Radioactive Tracer Market Size, Scope, and Share by 2030
Radioactive Tracer Market: Strategic Insights
Radioactive Tracer Market
-
CAGR (2022 - 2030)17.8% -
Market Size 2022
US$ 14.68 Billion -
Market Size 2030
US$ 54.3 Billion
Market Dynamics
GROWTH DRIVERS
- Rising Prevalence of Chronic Diseases
- Increased Use of Nuclear Imaging Techniques
FUTURE TRENDS
- Short Shelf-Life of Radioactive Tracers
- Availability of Substitutes to Nuclear Diagnosti Imaging Procedures
OPPORTUNITIES
- Use of Radioactive Tracers in Cancer Diagnosis
Key Players
- Rotem Industries Ltd
- Abx Advanced Biochemical Compounds Gmbh
- Invicro Llc
- Cardinal Health Inc
- Newcastle University
- Novartis AG
- Curium
- Blue Earth Diagnostics Limited
- General Electric Co
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Tracer Type - Technetium-99m & Tc-97m
- Iodine-131
- Iron-59
- Lutetium-171
- Rubidium Chloride & Ammonia
- Scandium-46
- Seaborgium-269
- Hassium-269
- Gallium Citrate Ga 67
- Prostate-Specific Membrane Antigen
- FDDNP & FDOPA
- Phosphorus-32 & Chromium-51
- Thallium-201
- F-18 FDG
- F-18 FAPI
- Ga-68 FAPI
- F-18 PSMA
- DOTATOC/DOTANOC/DOTATATE
Test Type - PET
- SPECT
Application - Oncology
- Pulmonary
- Neurology
- Cardiology
End User - Hospitals & Clinics
- Diagnostic Centers
- Academic & Research Institutes
Get Free Sample For